FindTrial
Sign In

Medicines given to Children in Asthma

Prescribing Trends In Asthma In Paediatrics: A Longitudinal, Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/10/021739
Enrollment
62
Registered
2019-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J45- Asthma

Interventions

Intervention1: NIL: NIL

Sponsors

Department of Pharmacology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of bronchial Asthma 2. Presence of wheeze in any child with a history of more than 4 episodes or use of bronchodilators within last 12 months.

Exclusion criteria

Exclusion criteria: Children having any other respiratory or cardiovascular disease or with alternative cause of recurrent wheezing.

Design outcomes

Primary

MeasureTime frame
Current prescribing trends in treatment of Asthma in childrenTimepoint: 1 month—

Secondary

MeasureTime frame
Change in PEFR ( Peak expiratory flow rate), any change in prescription and side effectsTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Amanpreet Kaur

Government Medical College, Patiala, Punjab

vijayksehgal@yahoo.com9646732001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026